Related Experiment Video

Updated: Mar 12, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
08:48

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis

Published on: March 19, 2019

7.5K

Recent advances on Candida albicans biology and virulence

Adnane Sellam1, Malcolm Whiteway2

  • 1Infectious Diseases Research Centre-CRI, CHU de Québec Research Center (CHUQ), Université Laval, Quebec City, Quebec, Canada; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada.

F1000Research
|November 18, 2016
PubMed

Insights

Candida albicans, a fungal pathogen, causes severe infections. New antifungal drugs are needed due to limited options and increasing resistance, necessitating a deeper understanding of its biology.

Area of Science:

  • Medical Mycology
  • Molecular Biology
  • Antimicrobial Drug Discovery

Background:

  • Candida albicans is a significant human fungal pathogen and opportunistic microbe.
  • It causes life-threatening infections in immunocompromised individuals.
  • Limited antifungal drugs and rising resistance highlight the urgent need for novel therapeutics.

Approach:

  • Reviewing recent molecular-level understanding of virulence trait regulation in C. albicans.
  • Highlighting technical advances in genome editing for C. albicans research.
  • Connecting biological insights to the identification of new antifungal drug targets.

Key Points:

  • Understanding C. albicans virulence mechanisms is crucial for developing new antifungal strategies.
  • Advances in genome editing tools enhance research capabilities for this pathogen.
  • Identifying novel molecular targets is essential to combat drug resistance.

Conclusions:

  • Continued research into C. albicans biology is vital for advancing antifungal drug discovery.
  • Improved understanding of virulence regulation and genome editing will accelerate the development of new treatments.
  • Addressing the need for novel antifungal therapies requires a multifaceted approach combining basic science and technological innovation.
Keywords:
C. albicansCandida albicansantifungal drugsgenome editingvirulence

More Related Videos

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

6.0K
Clarifying and Imaging Candida albicans Biofilms11:09

Clarifying and Imaging Candida albicans Biofilms

Published on: March 6, 2020

13.7K

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
664
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
824